Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7291 AL 7305

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116.

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

Palmqvist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, Londos E, Hansson O.

PLoS One. 2012;7(6):e38639. doi: 10.1371/journal.pone.0038639. Epub 2012 Jun 22.

Genome-wide association study of Alzheimer's disease

Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative; Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM.

Transl Psychiatry. 2012 May 15;2(5):e117. doi: 10.1038/tp.2012.45.

Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease

Browndyke JN, Giovanello K, Petrella J, Hayden K, Chiba-Falek O, Tucker KA, Burke JR, Welsh-Bohmer KA.

Alzheimers Dement. 2013 May;9(3):284-94. doi: 10.1016/j.jalz.2011.12.006. Epub 2012 Jul 28.

The imbalance of vascular molecules in Alzheimer's disease

Bell RD.

J Alzheimers Dis. 2012;32(3):699-709. doi: 10.3233/JAD-2012-121060.

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 Aug 28;79(9):897-905. doi: 10.1212/WNL.0b013e318266fa70. Epub 2012 Aug 1.

Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment

Visser PJ, Wolf H, Frisoni G, Gertz HJ.

Biomark Med. 2012 Aug;6(4):365-8. doi: 10.2217/bmm.12.58.

Mild cognitive impairment: a subset of minor neurocognitive disorder?

Geda YE, Nedelska Z.

Am J Geriatr Psychiatry. 2012 Oct;20(10):821-6. doi: 10.1097/JGP.0b013e31826abc00.

Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis

Jin C, Li W, Yuan J, Xu W, Cheng Z.

Neurosci Lett. 2012 Oct 3;527(1):46-9. doi: 10.1016/j.neulet.2012.08.032. Epub 2012 Aug 27.

The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis

Koyama A, O'Brien J, Weuve J, Blacker D, Metti AL, Yaffe K.

J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):433-40. doi: 10.1093/gerona/gls187. Epub 2012 Sep 14.

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?

Olah Z, Pakaski M, Janka Z, Kalman J.

Neuropsychopharmacol Hung. 2012 Sep;14(3):165-76.

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention

Vanitallie TB.

Metabolism. 2013 Jan;62 Suppl 1:S30-3. doi: 10.1016/j.metabol.2012.08.024. Epub 2012 Sep 26.

Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease

Bullock JM, Medway C, Cortina-Borja M, Turton JC, Prince JA, Ibrahim-Verbaas CA, Schuur M, Breteler MM, van Duijn CM, Kehoe PG, Barber R, Coto E, Alvarez V, Deloukas P, Hammond N, Combarros O, Mateo I, Warden DR, Lehmann MG, Belbin O, Brown K, Wilcock GK, Heun R, Kölsch H, Smith AD, Lehmann DJ, Morgan K.

Neurobiol Aging. 2013 Apr;34(4):1309.e1-7. doi: 10.1016/j.neurobiolaging.2012.08.010. Epub 2012 Oct 1.

Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia

Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, Walton J, Desai M, Solomon DF, Molena E, Worrall R, Hayen A, Choudhary P, Ladds E, Lanctôt KL, Verhey FR, McCleery JM, Mead GE, Clare L, Fioravanti M, Hyde C, Marcus S, McShane R.

Alzheimers Dement. 2013 May;9(3):e96-e105. doi: 10.1016/j.jalz.2012.01.014. Epub 2012 Oct 27.

New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician

Budson AE, Solomon PR.

Neurologist. 2012 Nov;18(6):356-63. doi: 10.1097/NRL.0b013e31826a998d.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias